InvestorsHub Logo
Followers 79
Posts 24502
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 09/09/2021 7:35:03 AM

Thursday, September 09, 2021 7:35:03 AM

Post# of 27408
SNGX - 1.05 Pre-market 1.21/1.22

FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma

https://stockcharts.com/h-sc/ui?s=SNGX

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.